IDH1 and central nervous system cancer: In the TCGA glioma dataset, the high‐risk group had higher proportions of older, high‐grade, low KPS, IDH wild‐type, MGMT unmethylated, 1p/19q noncodel, mesenchymal, and IGS‐23 subtype patients (all p < 0.05) (Table S8).